BAXALTA INCORPORATED

THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME

#2 | 2022-06-09

US20220175939A1

THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME

#3 | 2021-09-23 ✅ Patent 12,303,463 granted on 2025-05-20

US20210290486A1

Female-female adapter

#4 | 2021-06-03

US20210163990A1

AAV COMPOSITIONS

#5 | 2021-05-06

US20210128701A1

COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION

#6 | 2021-02-04 ✅ Patent 12,258,540 granted on 2025-03-25

US20210032567A1

Environmentally compatible detergents for inactivation of lipid-enveloped viruses

#7 | 2021-01-28 ✅ Patent 11,081,211 granted on 2021-08-03

US20210027876A1

Method and apparatus for providing a pharmacokinetic drug dosing regimen

#8 | 2020-12-03 ✅ Patent 11,564,979 granted on 2023-01-31

US20200376098A1

Stabilized liquid and lyophilized ADAMTS13 formulations

#9 | 2020-10-22 ✅ Patent 11,981,934 granted on 2024-05-14

US20200332266A1

Adeno-associated virus purification methods

#10 | 2020-09-10

US20200282132A1

SUBCUTANEOUS INFUSION DEVICE FOR INJECTING MEDICINAL SUBSTANCES

#11 | 2020-09-03 ✅ Patent 11,421,202 granted on 2022-08-23

US20200277565A1

Virus filtration of cell culture media

#12 | 2020-07-02 ✅ Patent 10,905,746 granted on 2021-02-02

US20200206318A1

Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

#13 | 2020-05-21 ✅ Patent 11,684,548 granted on 2023-06-27

US20200155413A1

Pooling device for single or multiple medical containers

#14 | 2020-04-02 ✅ Patent 11,185,575 granted on 2021-11-30

US20200101144A1

Subcutaneous administration of ADAMTS13

#15 | 2020-03-12 ✅ Patent 11,020,459 granted on 2021-06-01

US20200078447A1

Factor VIII formulations

#16 | 2020-01-16

US20200018752A1

Performing operations; transporting

METHODS FOR DETERMINING POTENCY OF ADENO-ASSOCIATED VIRUS PREPARATIONS

#17 | 2020-01-16 ✅ Patent 11,090,583 granted on 2021-08-17

US20200016515A1

Bottom section for being connected to an assembly with plate settler, and assembly with plate settler

#18 | 2019-12-19 ✅ Patent 10,934,340 granted on 2021-03-02

US20190382467A1

Separation of VWF and VWF propeptide by chromatographic methods

#19 | 2019-12-05 ✅ Patent 11,000,561 granted on 2021-05-11

US20190365835A1

Adeno-associated virus purification methods

#20 | 2019-11-07 ✅ Patent 11,191,818 granted on 2021-12-07

US20190336588A1

Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome

#21 | 2019-10-24 ✅ Patent 11,957,867 granted on 2024-04-16

US20190321542A1

Syringe stabilizer

#22 | 2019-09-05 ✅ Patent 11,921,117 granted on 2024-03-05

US20190271706A1

Characterization of subvisible particles using a particle analyzer

#23 | 2019-08-22 ✅ Patent 11,583,563 granted on 2023-02-21

US20190255126A1

Adeno-associated virus formulations

#24 | 2019-08-15 ✅ Patent 10,758,599 granted on 2020-09-01

US20190247475A1

Stabilized liquid and lyophilized ADAMTS13 formulations

#25 | 2019-08-01 ✅ Patent 11,160,850 granted on 2021-11-02

US20190231855A1

Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders

#26 | 2019-07-25 ✅ Patent 10,822,376 granted on 2020-11-03

US20190225648A1

Biologically active peptides

#27 | 2019-06-27 ✅ Patent 11,098,132 granted on 2021-08-24

US20190194351A1

Anti-factor IX Padua antibodies

#28 | 2019-06-06 ✅ Patent 10,875,906 granted on 2020-12-29

US20190169272A1

Removal of serine proteases by treatment with finely divided silicon dioxide

#29 | 2019-05-30 ✅ Patent 11,124,787 granted on 2021-09-21

US20190161746A1

ADAMTS13-containing compositions having thrombolytic activity

#30 | 2019-05-16 ✅ Patent 10,900,979 granted on 2021-01-26

US20190145989A1

Methods for testing effectiveness of a von Willebrand factor used in treating von Willebrand disease (VWD)

#31 | 2019-05-09 ✅ Patent 11,793,855 granted on 2023-10-24

US20190134147A1

Performing operations; transporting

TFPI inhibitors and methods of use

#32 | 2019-04-18

US20190111437A1

RECEPTACLE FOR ONE OR MORE SAMPLE CONTAINERS

#33 | 2019-03-28 ✅ Patent 10,632,176 granted on 2020-04-28

US20190091299A1

Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

#34 | 2019-03-21 ✅ Patent 10,822,394 granted on 2020-11-03

US20190085052A1

Method of producing recombinant high molecular weight vWF in cell culture

#35 | 2019-03-14 ✅ Patent 10,655,099 granted on 2020-05-19

US20190078051A1

Animal protein-free media for cultivation of cells

#36 | 2019-03-07 ✅ Patent 10,724,024 granted on 2020-07-28

US20190071660A1

Cell culture methods for expressing ADAMTS protein

#37 | 2019-02-28 ✅ Patent 11,299,533 granted on 2022-04-12

US20190062403A1

Performing operations; transporting

Purification of factor VIII subspecies

#38 | 2019-01-24

US20190022654A1

METHOD FOR INCUBATING LIQUIDS

#39 | 2018-11-29 ✅ Patent 10,842,853 granted on 2020-11-24

US20180339026A1

Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B

#40 | 2018-10-18 ✅ Patent 11,305,000 granted on 2022-04-19

US20180296656A1

Chimeric OspA genes, proteins and methods of use thereof

#41 | 2018-08-02 ✅ Patent 10,626,166 granted on 2020-04-21

US20180215807A1

Detection of CHO-MIF contaminations

#42 | 2018-07-26 ✅ Patent 10,238,720 granted on 2019-03-26

US20180207245A1

Stabilized liquid and lyophilized ADAMTS13 formulations

#43 | 2018-07-19 ✅ Patent 10,772,968 granted on 2020-09-15

US20180200380A1

Glycopolysialylation of non-blood coagulation proteins

#44 | 2018-06-07 ✅ Patent 10,800,816 granted on 2020-10-13

US20180155399A1

TFPI inhibitors and methods of use

#45 | 2018-04-26 ✅ Patent 10,723,761 granted on 2020-07-28

US20180111961A1

Protein purification by anion exchange chromatography

#46 | 2018-04-26

US20180110842A1

COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION

#47 | 2018-03-15 ✅ Patent 11,001,613 granted on 2021-05-11

US20180072784A1

TFPI inhibitors and methods of use

#48 | 2018-03-01 ✅ Patent 10,208,106 granted on 2019-02-19

US20180057568A1

Removal of serine proteases by treatment with finely divided silicon dioxide

#49 | 2018-02-22 ✅ Patent 10,221,400 granted on 2019-03-05

US20180051261A1

Method of producing a polypeptide or virus of interest in a continuous cell culture

#50 | 2018-02-15 ✅ Patent 10,100,099 granted on 2018-10-16

US20180044405A1

Method of producing recombinant high molecular weight vWF in cell culture

#51 | 2018-01-25 ✅ Patent 10,138,461 granted on 2018-11-27

US20180023048A1

Animal protein-free media for cultivation of cells

#52 | 2017-12-28

US20170369853A1

FORMULATION OF SUGAR SOLUTIONS FOR CONTINUOUS ULTRACENTRIFUGATION FOR VIRUS PURIFICATION

#53 | 2017-12-28 ✅ Patent 10,576,160 granted on 2020-03-03

US20170368193A1

Nucleophilic catalysts for oxime linkage

#54 | 2017-12-21 ✅ Patent 10,696,731 granted on 2020-06-30

US20170362300A1

Oligopeptide-free cell culture media

#55 | 2017-09-21 ✅ Patent 9,809,796 granted on 2017-11-07

US20170267969A1

Animal protein-free media for cultivation of cells

#56 | 2017-09-14

US20170260498A1

VIRUS FILTRATION OF CELL CULTURE MEDIA

#57 | 2017-08-24

US20170240867A1

VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVES

#58 | 2017-08-17 ✅ Patent 10,189,888 granted on 2019-01-29

US20170233455A1

Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

#59 | 2017-08-10

US20170226487A1

RECOMBINANT CO-EXPRESSION OF VITAMIN K EPOXIDE REDUCTASE SUBUNIT 1 TO IMPROVE VITAMIN K DEPENDENT PROTEIN EXPRESSION

#60 | 2017-08-10 ✅ Patent 10,189,889 granted on 2019-01-29

US20170226188A1

Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

#61 | 2017-08-10 ✅ Patent 10,413,600 granted on 2019-09-17

US20170224785A1

Subcutaneous administration of ADAMTS13

#62 | 2017-08-03 ✅ Patent 10,738,107 granted on 2020-08-11

US20170218051A1

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs

#63 | 2017-07-13

US20170196994A1

MODELS OF THROMBOTIC THROMBOCYTOPENIC PURPURA AND METHODS OF USE THEREOF

#64 | 2017-06-22 ✅ Patent 9,873,720 granted on 2018-01-23

US20170174727A1

TFPI inhibitors and methods of use

#65 | 2017-06-22 ✅ Patent 10,287,319 granted on 2019-05-14

US20170174724A1

Biologically active peptides

#66 | 2017-06-15 ✅ Patent 10,632,252 granted on 2020-04-28

US20170165419A1

Subcutaneous infusion device for injecting medicinal substances

#67 | 2017-06-08 ✅ Patent 10,201,586 granted on 2019-02-12

US20170157198A1

TFPI inhibitors and methods of use

#68 | 2017-06-01

US20170153256A1

METHODS FOR TREATING BLEEDING DISORDERS USING A PLATELET SUBPOPULATION

#69 | 2017-06-01 ✅ Patent 10,209,263 granted on 2019-02-19

US20170153255A1

Methods of measuring adamts 13 activity

#70 | 2017-05-04

US20170119857A1

Method of Administering Porcine B-Domainless fVIII

#71 | 2017-04-27 ✅ Patent 9,937,244 granted on 2018-04-10

US20170112906A1

Stabilized liquid and lyophilized ADAMTS13 formulations

#72 | 2017-03-30 ✅ Patent 10,640,741 granted on 2020-05-05

US20170088806A1

Stirred tank reactor systems and methods of use

#73 | 2017-02-23 ✅ Patent 10,072,254 granted on 2018-09-11

US20170051270A1

Cell culture methods for expressing ADAMTS13 protein

#74 | 2017-02-16 ✅ Patent 10,144,776 granted on 2018-12-04

US20170044244A1

Treatment of central nervous system disorders by intranasal administration of immunoglobulin G

#75 | 2017-02-09 ✅ Patent 10,124,033 granted on 2018-11-13

US20170035835A1

Peptides and methods of use

#76 | 2017-01-12 ✅ Patent 9,834,591 granted on 2017-12-05

US20170008948A1

Method of producing recombinant high molecular weight vWF in cell culture

#77 | 2017-01-05 ✅ Patent 9,669,076 granted on 2017-06-06

US20170000854A1

Albumin-free factor VIII formulations

#78 | 2016-12-29 ✅ Patent 9,572,778 granted on 2017-02-21

US20160375111A1

Stabilized liquid and lyophilized ADAMTS13 formulations

#79 | 2016-12-22 ✅ Patent 9,982,286 granted on 2018-05-29

US20160369316A1

Medium for the protein-free and serum-free cultivation of cells

#80 | 2016-12-15 ✅ Patent 10,350,301 granted on 2019-07-16

US20160361430A1

Blood coagulation protein conjugates

#81 | 2016-11-17 ✅ Patent 10,613,100 granted on 2020-04-07

US20160334414A1

Anti-MIF immunohistochemistry

#82 | 2016-11-10 ✅ Patent 10,527,551 granted on 2020-01-07

US20160327484A1

Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use

#83 | 2016-10-27 ✅ Patent 9,708,391 granted on 2017-07-18

US20160311889A1

Removal of serine proteases by treatment with finely divided silicon dioxide

#84 | 2016-08-25 ✅ Patent 10,125,189 granted on 2018-11-13

US20160244512A1

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

#85 | 2016-05-12 ✅ Patent 10,251,941 granted on 2019-04-09

US20160129121A1

Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life

#86 | 2016-05-12 ✅ Patent 10,232,022 granted on 2019-03-19

US20160129090A1

Lyophilized recombinant VWF formulations

#87 | 2016-03-24 ✅ Patent 9,714,411 granted on 2017-07-25

US20160083689A1

Animal protein-free media for cultivation of cells

#88 | 2016-03-10 ✅ Patent 9,758,568 granted on 2017-09-12

US20160068587A1

Oligopeptide-free cell culture media

#89 | 2016-03-03 ✅ Patent 9,732,327 granted on 2017-08-15

US20160060603A1

Formulation of sugar solutions for continuous ultracentrifugation for virus purification

#90 | 2016-03-03 ✅ Patent 9,598,464 granted on 2017-03-21

US20160060295A1

Biologically active peptides

#91 | 2016-02-18 ✅ Patent 9,873,892 granted on 2018-01-23

US20160046957A1

Production of fully processed and functional factor X in a furin-secreting mammalian expression system

#92 | 2016-02-18 ✅ Patent 10,036,002 granted on 2018-07-31

US20160046922A1

Factor X activation

#93 | 2016-02-11 ✅ Patent 10,202,417 granted on 2019-02-12

US20160039869A1

Purification method for vitamin K dependent proteins by anion exchange chromatography

#94 | 2016-02-04 ✅ Patent 9,488,651 granted on 2016-11-08

US20160033506A1

Methods of measuring ADAMTS 13 activity

#95 | 2015-12-10 ✅ Patent 10,053,500 granted on 2018-08-21

US20150353625A1

Variant of antihemophilic factor VIII having increased specific activity

#96 | 2015-11-19 ✅ Patent 9,441,216 granted on 2016-09-13

US20150329848A1

Cell culture medium for ADAMTS protein expression

#97 | 2015-09-03 ✅ Patent 9,447,147 granted on 2016-09-20

US20150246947A1

Peptides and methods of use

#98 | 2015-08-20 ✅ Patent 9,834,593 granted on 2017-12-05

US20150232536A1

IgG stimulated remyelination of peripheral nerves

#99 | 2015-08-20 ✅ Patent 9,556,230 granted on 2017-01-31

US20150232514A1

TFPI inhibitors and methods of use

#100 | 2015-07-23 ✅ Patent 9,512,198 granted on 2016-12-06

US20150203567A1